The central role of glutathione peroxidase 4 in the regulation of ferroptosis and its implications for pro-inflammatory cytokine-mediated beta-cell death

Author(s):  
Bastian Krümmel ◽  
Thomas Plötz ◽  
Anne Jörns ◽  
Sigurd Lenzen ◽  
Ilir Mehmeti
Diabetologia ◽  
2014 ◽  
Vol 57 (4) ◽  
pp. 765-775 ◽  
Author(s):  
Yoo Jin Park ◽  
Minna Woo ◽  
Timothy J. Kieffer ◽  
Razqallah Hakem ◽  
Nooshin Safikhan ◽  
...  

Diabetes ◽  
2001 ◽  
Vol 50 (Supplement 1) ◽  
pp. S44-S47 ◽  
Author(s):  
J. Chandra ◽  
B. Zhivotovsky ◽  
S. Zaitsev ◽  
L. Juntti-Berggren ◽  
P. Berggren ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2115-P
Author(s):  
HALESHA D. BASAVARAJAPPA ◽  
JOSE M. IRIMIA-DOMINGUEZ ◽  
PATRICK T. FUEGER
Keyword(s):  

Diabetes ◽  
2001 ◽  
Vol 50 (Supplement 1) ◽  
pp. S52-S57 ◽  
Author(s):  
D. Pipeleers ◽  
A. Hoorens ◽  
M. Marchial-Pipeleers ◽  
M. Van de Casteele ◽  
L. Bouwens ◽  
...  

2015 ◽  
Vol 35 (4) ◽  
pp. 1537-1545 ◽  
Author(s):  
Madhura Panse ◽  
Felicia Gerst ◽  
Gabriele Kaiser ◽  
Charlott-Amélie Teutsch ◽  
Rebecca Dölker ◽  
...  

Aims: GPR40/FFAR1 mediates palmitate-induced stimulation of insulin secretion but its involvement in lipotoxicity is controversial. Our previous observations suggest that FFAR1/GPR40 agonists protect against lipotoxicity although the underlying mechanism remains elusive. The present study examines the role of ERK1/2 and GPR40/FFAR1 in palmitate-induced stimulation of insulin secretion and beta cell death. Methods: Insulin secretion of INS-1E cells was measured by radioimmunoassay. Protein phosphorylation was examined on Western blots. Apoptosis was assessed by TUNEL staining. Results: Palmitate and the GPR40/FFAR1 agonist TUG-469 increased phosphorylation of ERK1/2 at low (2.8 mmol/L) and high (12 mmol/L) glucose but stimulated insulin secretion only at high glucose. The MEK1 inhibitor PD98059 significantly reduced phosphorylation of ERK1/2 but did not reverse the stimulation of secretion induced by glucose, palmitate or TUG-469. PD98059 rather augmented glucose-induced secretion. Prolonged exposure to palmitate stimulated apoptosis, an effect counteracted by TUG-469. PD98059 accentuated palmitate-induced apoptosis and reversed TUG-469-mediated inhibition of cell death. Conclusions: Activation of ERK1/2 by palmitate and GPR40/FFAR1 agonist correlates neither with stimulation of insulin secretion nor with induction of apoptosis. The results suggest a significant anti-apoptotic role of ERK1/2 under conditions of lipotoxicity.


2019 ◽  
Vol 20 (21) ◽  
pp. 5317
Author(s):  
Changhwan Ahn ◽  
Eui-Man Jung ◽  
Beum-Soo An ◽  
Eui-Ju Hong ◽  
Yeong-Min Yoo ◽  
...  

Intracellular calcium ion content is tightly regulated for the maintenance of cellular functions and cell survival. Calbindin-D9k (CaBP-9k) is responsible for regulating the distribution of cytosolic free-calcium ions. In this study, we aimed to investigate the effect of CaBP-9k on cell survival in pancreatic beta cells. Six-month-old wildtype CaBP-9k, CaBP-28k, and CaBP-9k/28k knockout (KO) mice were used to compare the pathological phenotypes of calcium-binding protein-deleted mice. Subsequently, the endoplasmic reticulum (ER) stress reducer tauroursodeoxycholic acid (TUDCA) was administered to wildtype and CaBP-9k KO mice. In vitro assessment of the role of CaBP-9k was performed following CaBP-9k overexpression and treatment with the ER stress inducer thapsigargin. Six-month-old CaBP-9k KO mice showed reduced islet volume and up-regulation of cell death markers resulting from ER stress, which led to pancreatic beta cell death. TUDCA treatment recovered islet volume, serum insulin level, and abdominal fat storage by CaBP-9k ablation. CaBP-9k overexpression elevated insulin secretion and recovered thapsigargin-induced ER stress in the INS-1E cell line. The results of this study show that CaBP-9k can protect pancreatic beta cell survival from ER stress and contribute to glucose homeostasis, which can reduce the risk of type 1 diabetes and provide the molecular basis for calcium supplementation to diabetic patients.


PLoS ONE ◽  
2017 ◽  
Vol 12 (7) ◽  
pp. e0181235 ◽  
Author(s):  
Sandeep Kumar ◽  
Claire E. Marriott ◽  
Nouf F. Alhasawi ◽  
Adrian J. Bone ◽  
Wendy M. Macfarlane

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 82-OR
Author(s):  
ANDREW T. TEMPLIN ◽  
MEGHAN F. HOGAN ◽  
NATHALIE ESSER ◽  
SAKENEH ZRAIKA ◽  
REBECCA L. HULL ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document